Medical doctors prescribe GLP-1 receptor agonists, together with semaglutide and tirzepatide, to deal with sort 2 diabetes and weight problems. In addition to bettering blood sugar management and selling weight reduction, these medication may reduce the danger of cardiovascular and kidney illness.
Individuals with sort 2 diabetes have a higher risk of creating lengthy COVID and pulmonary fibrosis, a situation the place scar tissue builds up within the lungs and makes respiratory tougher.
Within the new research, researchers mixed analyses of human samples with experiments in mice to higher perceive how sort 2 diabetes contributes to lengthy COVID-related pulmonary fibrosis.
They first analyzed knowledge from an earlier long COVID study involving 90 folks hospitalized with COVID-19, together with 11 with sort 2 diabetes and 79 with out. They in contrast immune cell exercise throughout hospitalization and once more 2 to three months later, searching for variations in genes linked to irritation and lung scarring.
Subsequent, they contaminated diabetic and non-diabetic mice with SARS-CoV-2 to match the consequences of diabetes on long-term lung harm.
In one other experiment, the researchers depleted macrophages, immune cells concerned in irritation, to find out whether or not they contributed to lung scarring after an infection.
Lastly, they handled contaminated diabetic mice with a GLP-1 receptor agonist and in contrast them with untreated mice.
In each the human and mouse experiments, the researchers discovered constant proof linking sort 2 diabetes to lengthy COVID-related lung scarring.
Within the human evaluation, folks with sort 2 diabetes confirmed elevated exercise in monocytes, immune cells that may become macrophages, for as much as 3 months after COVID-19.
Additionally they had larger ranges of genes and proteins linked to irritation and pulmonary fibrosis than folks with out diabetes.
The primary mouse experiment produced related outcomes. Diabetic mice developed extra extreme infections, skilled higher weight reduction and better viral hundreds, and confirmed elevated exercise of a fibrosis-related gene not noticed in non-diabetic mice.
In one other experiment, diabetic mice had extra lung-infiltrating macrophages after SARS-CoV-2 an infection than non-diabetic mice.
When researchers eliminated these immune cells, the mice developed much less lung irritation and scarring, suggesting macrophages play an vital position in lung harm.
Within the closing experiment, the researchers examined whether or not GLP-1 drugs might scale back lung harm. In contrast with untreated diabetic mice, handled mice developed considerably much less lung scarring.
Extra assessments indicated that the medication altered macrophage responses to an infection.
How COVID-19 drives lung harm
Lead research creator Runhong Zhou, PhD, a virologist on the College of Hong Kong, stated the findings level to inflammatory macrophages as a key driver of lung scarring.
“We predict that COVID-19 infection-induced proinflammatory macrophage infiltration is a serious driver of lengthy COVID-related pulmonary fibrosis,” Zhou shared with Medical Information At present.
“GLP-1 receptor agonists scale back this macrophage infiltration and normalize the expression of fibrosis-related genes,” Zhou continued.
Zhou emphasised that the findings are preliminary as a result of they’re based mostly on a small variety of mice and require affirmation in bigger animal research and finally in people.
Gillian Goddard, MD, a board-certified endocrinologist with Park Avenue Endocrinology and Vitamin, spoke with MNT concerning the research findings.
Goddard known as the findings “thrilling,” however stated they don’t seem to be sufficient to alter medical observe.
“We’ll want some research in folks earlier than we will say that GLP-1 is useful for treating lengthy COVID,” she stated.
Goddard stated folks with sort 2 diabetes have already got larger baseline irritation, which can assist clarify their elevated danger of lengthy COVID problems.
“Primarily, somebody with sort 2 diabetes has larger baseline irritation, then you definitely add irritation from COVID on high of that, and it will probably result in way more extreme signs,” she stated, including that
Fady Youssef, MD, a board licensed pulmonologist, internist, and important care specialist at MemorialCare Lengthy Seashore Medical Heart, additionally spoke with MNT.
Youssef stated one of many research’s most intriguing findings is that GLP-1 drugs appeared to cut back lung scarring even with out considerably bettering blood sugar ranges.
“GLP-1 medication diminished lung scarring even when blood sugar ranges weren’t considerably improved, suggesting the medication could immediately reprogram the immune cells driving the harm,” he stated.
Youssef famous {that a} previous clinical trial discovered that metformin diminished the danger of lengthy COVID, suggesting that it and GLP-1 medication could act by way of related organic pathways.
“Since metformin is known to boost natural GLP-1 levels within the physique, this research raises the likelihood that each medication could also be working by means of the identical mechanism,” he stated.
